• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[重排影响甲状腺乳头状癌的多灶性形成]

[/ rearrangement affects multifocal formation of papillary thyroid carcinoma].

作者信息

Zhang X, Su X, Chen W C, Li Y, Yang Z Y, Deng W Z, Deng T C, Yang A K

机构信息

Department of Head and Neck Surgery, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.

出版信息

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jun 7;52(6):435-439. doi: 10.3760/cma.j.issn.1673-0860.2017.06.008.

DOI:10.3760/cma.j.issn.1673-0860.2017.06.008
PMID:28635216
Abstract

/ gene rearrangement can lead to aberrant activation of tyrosine kinase receptors, which is a common mutation in papillary thyroid carcinoma (PTC). This study focuses on the association of / rearrangements with PTC clinical factors. From January 2011 to December 2013, a total of 114 patients with PTC were enrolled in this study. Clinicopathological parameters, lifestyle, and thyroid hormone levels were collected. / rearrangements were detected by TaqMan PCR and verified by Sanger sequencing.Data were analyzed with SPSS software, including chi-square test, ' exact test, - test, '-test, and Logistic regression. / rearrangements were not found in all paracancerous normal thyroid tissues, and were detected in 23.68% (27/114) of PTC. Further analysis revealed no correlation between / rearrangement and thyroid function, clinicopathologic parameters, and lifestyle in the total PTC group or in the subgroup of patients with concomitant diseases (including Hashimoto's thyroiditis and nodular goiter). But in the subgroup of PTC without concomitant disease, / rearrangement was associated with tumor multifocal (=0.018), and /-positive PTC patients had an increased risk of tumor multifocal (=5.57, 95% 1.39-22.33). It was also found that / rearrangement was associated with an abnormal increase in TSH level of one month after surgery (= 0.037). Nodular goiter and Hashimoto 's thyroiditis may be a confounding factor in PTC. / rearrangement may play an important role in the occurrence of thyroid carcinoma multifocal after exclusion of this confounding factor.

摘要

/基因重排可导致酪氨酸激酶受体异常激活,这是甲状腺乳头状癌(PTC)中常见的突变。本研究聚焦于/重排与PTC临床因素的关联。2011年1月至2013年12月,本研究共纳入114例PTC患者。收集了临床病理参数、生活方式和甲状腺激素水平。通过TaqMan PCR检测/重排,并通过桑格测序进行验证。使用SPSS软件进行数据分析,包括卡方检验、确切概率检验、t检验、t'检验和逻辑回归。在所有癌旁正常甲状腺组织中均未发现/重排,在23.68%(27/114)的PTC中检测到。进一步分析显示,在整个PTC组或伴有疾病(包括桥本甲状腺炎和结节性甲状腺肿)的患者亚组中,/重排与甲状腺功能、临床病理参数和生活方式之间无相关性。但在无伴发疾病的PTC亚组中,/重排与肿瘤多灶性相关(P = 0.018),/阳性的PTC患者发生肿瘤多灶性的风险增加(P = 5.57,95%CI 1.39 - 22.33)。还发现/重排与术后1个月TSH水平异常升高相关(P = 0.037)。结节性甲状腺肿和桥本甲状腺炎可能是PTC中的一个混杂因素。排除该混杂因素后,/重排在甲状腺癌多灶性的发生中可能起重要作用。

相似文献

1
[/ rearrangement affects multifocal formation of papillary thyroid carcinoma].[重排影响甲状腺乳头状癌的多灶性形成]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jun 7;52(6):435-439. doi: 10.3760/cma.j.issn.1673-0860.2017.06.008.
2
RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.RET/PTC重排与甲状腺乳头状癌术后促甲状腺激素(TSH)水平升高及多灶性病变相关,且不伴有甲状腺良性疾病。
PLoS One. 2016 Nov 1;11(11):e0165596. doi: 10.1371/journal.pone.0165596. eCollection 2016.
3
Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.甲状腺乳头状癌弥漫性硬化变异型:主要基因改变及预后意义
Histopathology. 2016 Jul;69(1):45-53. doi: 10.1111/his.12902. Epub 2016 Jan 11.
4
Correlation Between the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated with Hashimoto's Thyroiditis, BRAF V600E Gene Mutation, and RET Gene Rearrangement.桥本甲状腺炎合并甲状腺乳头状癌的临床病理特征与 BRAF V600E 基因突变、RET 基因重排的相关性。
J Coll Physicians Surg Pak. 2024 Apr;34(4):445-450. doi: 10.29271/jcpsp.2024.04.445.
5
Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.甲状腺乳头状癌中常同时出现 BRAF(V600E) 突变和 RET/PTC 重排。
Thyroid. 2014 Feb;24(2):254-9. doi: 10.1089/thy.2013.0235. Epub 2013 Aug 24.
6
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.非肿瘤性甲状腺细胞中的RET/甲状腺乳头状癌重排:桥本甲状腺炎的滤泡细胞与一部分乳头状癌存在低水平的重组事件。
J Clin Endocrinol Metab. 2006 Jun;91(6):2414-23. doi: 10.1210/jc.2006-0240. Epub 2006 Apr 4.
7
Overexpression of wild-type c-RET and zero prevalence of RET/PTC rearrangements are associated with papillary thyroid cancer (PTC) in Kuwait.在科威特,野生型 c-RET 的过表达和 RET/PTC 重排的零发生率与甲状腺乳头状癌(PTC)有关。
Exp Mol Pathol. 2011 Feb;90(1):61-5. doi: 10.1016/j.yexmp.2010.10.002. Epub 2010 Oct 13.
8
[Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data].[甲状腺乳头状癌放疗后RET/PTC基因重排频率的剂量反应依赖性。分子流行病学数据的简单合并分析]
Radiats Biol Radioecol. 2016 Jan-Feb;56(1):5-25.
9
Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.在桥本甲状腺炎中,优势结节与甲状腺乳头状癌的区别在于 BRAF、NRAS、KRAS、HRAS 突变以及 RET/PTC 基因重排缺失。
Endocr Pathol. 2010 Jun;21(2):73-9. doi: 10.1007/s12022-009-9101-3.
10
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.通过BRAF V600E突变和RET/PTC重排的细针穿刺分子分析诊断甲状腺乳头状癌
Thyroid. 2007 Nov;17(11):1109-15. doi: 10.1089/thy.2007.0008.

引用本文的文献

1
Identification of thyroid cancer biomarkers using WGCNA and machine learning.使用加权基因共表达网络分析(WGCNA)和机器学习鉴定甲状腺癌生物标志物
Eur J Med Res. 2025 Apr 5;30(1):244. doi: 10.1186/s40001-025-02466-x.
2
The Difference in Clinical Behavior of Gene Fusions Involving Fusions and Fusions in Thyroid Nodules.甲状腺结节中涉及[具体融合基因]融合和[具体融合基因]融合的基因融合在临床行为上的差异。 (你原文中“Fusions and Fusions”表述不完整,这里是按格式补全后的翻译,实际需根据完整准确的内容进行翻译)
Cancers (Basel). 2023 Jun 28;15(13):3394. doi: 10.3390/cancers15133394.
3
Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
蛋白酪氨酸磷酸酶受体C型的上调与桥本甲状腺炎和乳头状甲状腺癌的联合相关,并预示预后不良。
Onco Targets Ther. 2019 Oct 14;12:8479-8489. doi: 10.2147/OTT.S226426. eCollection 2019.